Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Yixintang Pharmaceutical Group Co., Ltd., commonly referred to as Yixintang, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1992, the company has made significant strides in the development and distribution of traditional Chinese medicine and modern pharmaceuticals, serving both domestic and international markets.
With a focus on research and innovation, Yixintang offers a diverse range of products, including herbal remedies, over-the-counter medications, and prescription drugs. Their commitment to quality and efficacy sets them apart in a competitive landscape. Notably, Yixintang has achieved recognition for its contributions to healthcare, solidifying its position as a trusted name in the industry. Through continuous growth and expansion, Yixintang remains dedicated to enhancing health and well-being globally.
-18 vs industry average
Yixintang Pharmaceutical Group Co., Ltd.’s score of 18 is lower than 32% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Retail Trade Services has above-average carbon intensity
The Retail Trade Services industry has reduced its overall emissions by 31% since 2018
No reported emissions data is available for Yixintang Pharmaceutical Group Co., Ltd. yet.
Yixintang Pharmaceutical Group Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time.
As there are no emissions data or reduction initiatives available, Yixintang Pharmaceutical Group's climate commitments remain unclear. The company does not appear to inherit any emissions data from a parent organisation, indicating that it operates independently in this regard.
In the broader context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific data or commitments from Yixintang Pharmaceutical Group, it is difficult to assess their position within this evolving landscape.
No climate goals have been disclosed for Yixintang Pharmaceutical Group Co., Ltd. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more